Werewolf Therapeutics, Inc. — Director's Dealing 2021

May 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Werewolf Therapeutics, Inc. (HOWL)
CIK: 0001785530
Period of Report: 2021-02-12

Reporting Person: Trost Timothy W. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-12	Stock Option (right to buy)	$5.98	A	247812	Acquired	2031-02-11	Common Stock (247812)	Direct
2021-04-30	Stock Option (right to buy)	$16.00	A	54756	Acquired	2031-04-29	Common Stock (54756)	Direct

Footnotes

F1: The option was granted on February 12, 2021 with a Vesting Commencement Date of February 8, 2021. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the Vesting Commencement Date and 2.0833% of the shares vesting each month thereafter through February 8, 2025.

F2: The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.